University of Texas Health Science Center at Houston-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:University of Texas Health Science Center at Houston - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014154
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University of Texas Health Science Center at Houston (UTHealth), a subsidiary of University of Texas System is an educational institution that provides research, education and patient care services. The university operates with schools of biomedical informatics, biomedical sciences, dentistry, medicine, nursing and public health. It offers clinical research education course that is conducted by clinical trial research professionals and examines the entire clinical trial process. The university’s teaching hospitals include Memorial Hermann-Texas Medical Center, Children’s Memorial Hermann Hospital and Harris Health Lyndon B. Johnson General Hospital. UTHealth is headquartered in Houston, Texas, the US.

University of Texas Health Science Center at Houston – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 10
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 11
Licensing Agreements 12
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 12
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 13
Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 14
University of Texas Health Science Center at Houston – Key Competitors 15
University of Texas Health Science Center at Houston – Key Employees 16
University of Texas Health Science Center at Houston – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Government and Public Interest 19
Sep 28, 2017: UTHealth’s Jim Zheng awarded $5.8 million CPRIT grant to mine cancer data for cures 19
Aug 24, 2017: Research reveals how estrogen regulates gene expression 20
May 08, 2017: UTHealth researchers identify genes in children linked to stress, bipolar disorder 21
Sep 01, 2016: Mobile Stroke Unit Project Receives $6.8 Million from PCORI to Expand Research in Houston and Beyond 22
Jan 12, 2016: New NIH awards will support development of therapeutic alternatives to traditional antibiotics 24
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Key Facts 2
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
University of Texas Health Science Center at Houston, Deals By Therapy Area, 2011 to YTD 2017 8
University of Texas Health Science Center at Houston, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Immune-Onc Therapeutics Enters into Research Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 10
University of Texas Health Science Center Enters into Co-Development Agreement with Purdue Pharma 11
CSPC Pharma Enters into Licensing Agreement with University of Texas Health Science Center at San Antonio and University of Texas Health Science Center at Houston 12
Immune-Onc Therapeutics Enters into Licensing Agreement with University of Texas Health Science Center at Houston and University of Texas Southwestern Medical Center 13
Cellvation Enters into Licensing Agreement with University of Texas Health Science Center at Houston 14
University of Texas Health Science Center at Houston, Key Competitors 15
University of Texas Health Science Center at Houston, Key Employees 16
University of Texas Health Science Center at Houston, Other Locations 17
University of Texas Health Science Center at Houston, Subsidiaries 17

★海外企業調査レポート[University of Texas Health Science Center at Houston-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Business Power Corp:電力:M&Aディール及び事業提携情報
    Summary Global Business Power Corp (GBPC), formerly Mirant Global Corp, a subsidiary of ORIX Corp, is an energy utility that generates and distributes electricity. The utility produces reliable and cost-efficient power supply through its subsidiaries that operate power generation facilities. Its ser …
  • ProAxsis Ltd:企業の製品パイプライン分析2018
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • Hudson Pacific Properties Inc:企業のM&A・事業提携・投資動向
    Hudson Pacific Properties Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hudson Pacific Properties Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • ASC Pty Ltd:企業の戦略・SWOT・財務情報
    ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary ASC Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Western Farmers Electric Cooperative:企業の発電所・SWOT分析2018
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • LMI Aerospace, Inc.:企業の戦略的SWOT分析
    LMI Aerospace, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Suzlon Energy Limited:企業の戦略・SWOT・財務情報
    Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Suzlon Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alfa Laval AB (ALFA)-石油・ガス分野:企業M&A・提携分析
    Summary Alfa Laval AB (Alfa Laval) is a provider of specialized products and solutions for heat transfer, separation and fluid handling. Its product portfolio includes centrifuges, pumps and valves, heat exchangers, thermal fluid systems, boilers, decanters, burners, evaporation systems, high speed …
  • ANI Pharmaceuticals Inc (ANIP):製薬・医療:M&Aディール及び事業提携情報
    Summary ANI Pharmaceuticals Inc (ANI) formerly BioSante Pharmaceuticals Inc, is a specialty pharmaceutical company that develops, manufactures and markets pharmaceuticals. The company’s product portfolio encompasses generic and branded tablets indicated for ulcerative colitis; osteoarthritis; rheuma …
  • Bonduelle Sca
    Bonduelle Sca - Strategy, SWOT and Corporate Finance Report Summary Bonduelle Sca - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Empresas Copec S.A.:企業の戦略・SWOT・財務分析
    Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report Summary Empresas Copec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Nippon Shinyaku Co Ltd (4516):製薬・医療:M&Aディール及び事業提携情報
    Summary Nippon Shinyaku Co Ltd (Nippon) is a pharmaceutical company that develops, manufactures and sells ethical pharmaceuticals and functional foods. The company offers a wide range of products including drugs for pain, inflammation, and allergies; urological diseases; hematologic malignancies; ga …
  • Gas y Petroleo del Neuquen SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas y Petroleo del Neuquen SA (Gas Y Petroleo) operates as an oil and gas exploration company. It is engaged in the production and supply of hydrocarbon resources. The company holds 36 contracts with other companies, to develop exploratory and hydrocarbon exploitation activities. It is also …
  • Verona Pharma Plc (VRP):製薬・医療:M&Aディール及び事業提携情報
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • GFI Informatique (GFI):企業の財務・戦略的SWOT分析
    GFI Informatique (GFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Lotte Shopping Co., Ltd.:企業の戦略・SWOT・財務情報
    Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Lotte Shopping Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • TESCO Personal Finance Group Ltd:企業の戦略・SWOT・財務情報
    TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report Summary TESCO Personal Finance Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Rockefeller University-製薬・医療分野:企業M&A・提携分析
    Summary Rockefeller University (Rockefeller) is a biomedical research university that provides graduate and postdoctoral educational programs. The university offers various educational courses in the fields of biomedical sciences, chemistry, bioinformatics and physics. It conducts clinical studies i …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Mikros Systems Corporation:企業の戦略・SWOT・財務分析
    Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Mikros Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆